New targets for CF therapies: hyperosmolar agents

I. Sermet-Gaudelus (Paris, France)

Source: Annual Congress 2011 - New promising ways to treat cystic fibrosis
Session: New promising ways to treat cystic fibrosis
Session type: Symposium
Number: 1378

Slide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Sermet-Gaudelus (Paris, France). New targets for CF therapies: hyperosmolar agents. Annual Congress 2011 - New promising ways to treat cystic fibrosis

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
New therapeutic targets
Source: Annual Congress 2007 - COPD – a disease of accelerated ageing?
Year: 2007


New targets for drug development in asthma
Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium
Year: 2008


Antibiotics as immunomodulators: a potential pharmacologic approach for ARDS treatment
Source: Eur Respir Rev, 30 (162) 210093; 10.1183/16000617.0093-2021
Year: 2021



New therapeutic strategies in BOS
Source: Annual Congress 2007 - Bronchiolitis obliterans syndrome (BOS) after lung transplantation: new kids on the block
Year: 2007


New treatment approaches for IPF
Source: International Congress 2016 – ME2 New treatment approaches for idiopathic pulmonary fibrosis
Year: 2016



New antifibrotic drugs: will interstitial diseases patients still need lung transplantation?
Source: Virtual Congress 2020 – Lung transplantation in the era of new drugs
Year: 2020


New and repurposed drugs
Source: Eur Respir Monogr 2018; 82: 179-204
Year: 2018


Systemic therapies: optimising the sequences of chemotherapies, targeted therapies and immunotherapies
Source: International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy
Year: 2017


New cystic fibrosis therapy targets
Source: Research Seminar 2014 - Protein quality control in lung disease
Year: 2014

Inhaled therapy in cystic fibrosis: agents, devices and regimens
Source: Breathe 2015; 11:110-118
Year: 2015



Novel targets and emerging therapies in MPM
Source: ERS Skills course: Multi-disciplinary care in thoracic oncology
Year: 2019

New mechanisms and targets in COPD
Source: International Congress 2014 – ERS/CTS China Day: advances in asthma and COPD
Year: 2014



New drugs for severe asthma – what should we target and how?
Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Year: 2014


New anti-tuberculosis drugs and regimens: 2015 update
Source: ERJ Open Res 2015; 1: 00010-2015
Year: 2015



New drugs and drug regimens in the treatment of chronic and MDR-TB - what is on the horizon?
Source: Annual Congress 2005 - Challenges in the management of pulmonary tuberculosis: a continuous clinical problem
Year: 2005